Molecules/RAVULIZUMAB

RAVULIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2018

Mechanism of action: Complement C5 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ALXN-1210ALXN1210RAVULIZUMABRAVULIZUMAB CWVZRAVULIZUMAB-CWVZUltomiris

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to RAVULIZUMAB

Loading drug network...